(Q30457132)

21 June 2017

title

Advances in antivirals for non-influenza respiratory virus infections (English)

1 reference

Respiratory syncytial virus

21 June 2017

main subject

0 references

0 references

1

Frederick G Hayden

1 reference

21 June 2017

language of work or name

English

0 references

publication date

1 November 2013

1 reference

Influenza and Other Respiratory Viruses

21 June 2017

published in

1 reference

21 June 2017

volume

7 Suppl 3

1 reference

21 June 2017

page(s)

36-43

1 reference

Newer influenza antivirals, biotherapeutics and combinations

21 June 2017

cites work

1 reference

Antivirals in seasonal and pandemic influenza--future perspectives

21 January 2018

1 reference

Antiviral therapy and outcomes of patients with pneumonia caused by influenza A pandemic (H1N1) virus

21 January 2018

1 reference

Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies

21 January 2018

1 reference

Impact of neuraminidase inhibitor treatment on outcomes of public health importance during the 2009-2010 influenza A(H1N1) pandemic: a systematic review and meta-analysis in hospitalized patients

21 January 2018

1 reference

Treatment with neuraminidase inhibitors for critically ill patients with influenza A (H1N1)pdm09.

21 January 2018

1 reference

Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China

21 January 2018

1 reference

Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia

21 January 2018

1 reference

A novel coronavirus capable of lethal human infections: an emerging picture

21 January 2018

1 reference

Severe acute respiratory syndrome and coronavirus.

21 January 2018

1 reference

Cyclosporin A inhibits the replication of diverse coronaviruses

21 January 2018

1 reference

Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c mice

21 January 2018

1 reference

Coronaviruses and their therapy

21 January 2018

1 reference

Potential antivirals and antiviral strategies against SARS coronavirus infections

21 January 2018

1 reference

Pro/con clinical debate: steroids are a key component in the treatment of SARS. Pro: Yes, steroids are a key component of the treatment regimen for SARS

21 January 2018

1 reference

SARS: systematic review of treatment effects

21 January 2018

1 reference

The management of coronavirus infections with particular reference to SARS.

21 January 2018

1 reference

Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings.

21 January 2018

1 reference

Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin.

21 January 2018

1 reference

Serial analysis of the plasma concentration of SARS coronavirus RNA in pediatric patients with severe acute respiratory syndrome.

21 January 2018

1 reference

Common Adverse Events Associated with the Use of Ribavirin for Severe Acute Respiratory Syndrome in Canada

21 January 2018

1 reference

Inhibition of novel β coronavirus replication by a combination of interferon-α2b and ribavirin

21 January 2018

1 reference

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

Intranasal treatment with poly(I•C) protects aged mice from lethal respiratory virus infections

21 January 2018

1 reference

Exacerbated innate host response to SARS-CoV in aged non-human primates

21 January 2018

1 reference

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

21 January 2018

1 reference

Efficient replication of the novel human betacoronavirus EMC on primary human epithelium highlights its zoonotic potential

21 January 2018

1 reference

Tropism of and innate immune responses to the novel human betacoronavirus lineage C virus in human ex vivo respiratory organ cultures

21 January 2018

1 reference

Human monoclonal antibody as prophylaxis for SARS coronavirus infection in ferrets

21 January 2018

1 reference

Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters

21 January 2018

1 reference

Use of convalescent plasma therapy in SARS patients in Hong Kong

21 January 2018

1 reference

Experience of using convalescent plasma for severe acute respiratory syndrome among healthcare workers in a Taiwan hospital

21 January 2018

1 reference

Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC

21 January 2018

1 reference

Human coronavirus EMC does not require the SARS-coronavirus receptor and maintains broad replicative capability in mammalian cell lines

21 January 2018

1 reference

Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection

21 January 2018

1 reference

A single asparagine-linked glycosylation site of the severe acute respiratory syndrome coronavirus spike glycoprotein facilitates inhibition by mannose-binding lectin through multiple mechanisms

21 January 2018

1 reference

High-dose mannose-binding lectin therapy for Ebola virus infection

21 January 2018

1 reference

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

21 January 2018

1 reference

Mortality associated with influenza and respiratory syncytial virus in the United States

21 January 2018

1 reference

Antibodies for prevention and treatment of respiratory syncytial virus infections in children

21 January 2018

1 reference

Antiviral therapy of respiratory viruses in haematopoietic stem cell transplant recipients

21 January 2018

1 reference

Management of RSV infections in adult recipients of hematopoietic stem cell transplantation

21 January 2018

1 reference

Outcome of respiratory syncytial virus lower respiratory tract disease in hematopoietic cell transplant recipients receiving aerosolized ribavirin: significance of stem cell source and oxygen requirement

21 January 2018

1 reference

An adaptive randomized trial of an intermittent dosing schedule of aerosolized ribavirin in patients with cancer and respiratory syncytial virus infection

21 January 2018

1 reference

Respiratory syncytial virus infection in patients with hematological diseases: single-center study and review of the literature

21 January 2018

1 reference

Efficacy of oral ribavirin in hematologic disease patients with paramyxovirus infection: analytic strategy using propensity scores.

21 January 2018

1 reference

Antiviral therapies for respiratory viral infections in lung transplant patients

21 January 2018

1 reference

Single-centre experience with oral ribavirin in lung transplant recipients with paramyxovirus infections.

21 January 2018

1 reference

Safety and antiviral activity of motavizumab, a respiratory syncytial virus (RSV)-specific humanized monoclonal antibody, when administered to RSV-infected children

21 January 2018

1 reference

Motavizumab for prophylaxis of respiratory syncytial virus in high-risk children: a noninferiority trial

21 January 2018

1 reference

Targeting RSV with vaccines and small molecule drugs

21 January 2018

1 reference

RNA interference-mediated silencing of the respiratory syncytial virus nucleocapsid defines a potent antiviral strategy

21 January 2018

1 reference

The promise, pitfalls and progress of RNA-interference-based antiviral therapy for respiratory viruses

21 January 2018

1 reference

A randomized, double-blind, placebo-controlled study of an RNAi-based therapy directed against respiratory syncytial virus

21 January 2018

1 reference

RNA interference therapy in lung transplant patients infected with respiratory syncytial virus

21 January 2018

1 reference

Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.

21 January 2018

1 reference

DAS181, a novel sialidase fusion protein, protects mice from lethal avian influenza H5N1 virus infection.

21 January 2018

1 reference

Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.

21 January 2018

1 reference

A phase II study of DAS181, a novel host directed antiviral for the treatment of influenza infection

21 January 2018

1 reference

A recombinant sialidase fusion protein effectively inhibits human parainfluenza viral infection in vitro and in vivo

21 January 2018

1 reference

Clinical potential of DAS181 for treatment of parainfluenza-3 infections in transplant recipients

21 January 2018

1 reference

Treatment of Parainfluenza 3 Infection With DAS181 in a Patient After Allogeneic Stem Cell Transplantation

21 January 2018

1 reference

DAS181 treatment of severe parainfluenza type 3 pneumonia in a lung transplant recipient

21 January 2018

1 reference

A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14.

21 January 2018

1 reference

Safety and tolerability of cidofovir in high-risk pediatric patients

21 January 2018

1 reference

How I treat adenovirus in hematopoietic stem cell transplant recipients

21 January 2018

1 reference

Ether lipid-ester prodrugs of acyclic nucleoside phosphonates: activity against adenovirus replication in vitro

21 January 2018

1 reference

Hexadecyloxypropyl-cidofovir, CMX001, prevents adenovirus-induced mortality in a permissive, immunosuppressed animal model

21 January 2018

1 reference

Safety and efficacy of CMX001 as salvage therapy for severe adenovirus infections in immunocompromised patients

21 January 2018

1 reference

First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broad-spectrum oral drug active against double-stranded DNA viruses

21 January 2018

1 reference

Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials

21 January 2018

1 reference

Relationship of pleconaril susceptibility and clinical outcomes in treatment of common colds caused by rhinoviruses

21 January 2018

1 reference

Prophylactic efficacy of intranasal alpha 2-interferon against rhinovirus infections in the family setting

21 January 2018

1 reference

T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections.

21 January 2018

1 reference

Genetic screens for the control of influenza virus replication: from meta-analysis to drug discovery.

21 January 2018

1 reference

Identification of common biological pathways and drug targets across multiple respiratory viruses based on human host gene expression analysis

21 January 2018

1 reference

Treatment of severe acute respiratory syndrome with lopinavir/ritonavir: a multicentre retrospective matched cohort study.

21 January 2018

1 reference

12 December 2020

Pro/con clinical debate: steroids are a key component in the treatment of SARS. Con: No, steroids are not a key component of the treatment regimen for SARS

1 reference

12 December 2020

Using siRNA in prophylactic and therapeutic regimens against SARS coronavirus in Rhesus macaque

1 reference

12 December 2020

Differential susceptibility of adenovirus clinical isolates to cidofovir and ribavirin is not related to species alone.

1 reference

12 December 2020

Deaths associated with human adenovirus-14p1 infections, Europe, 2009-2010

1 reference

12 December 2020

Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012.

1 reference

12 December 2020

Evidence of person-to-person transmission within a family cluster of novel coronavirus infections, United Kingdom, February 2013.

1 reference

12 December 2020

Prevention of natural colds by contact prophylaxis with intranasal alpha 2-interferon

1 reference

12 December 2020

Identifiers

DOI

10.1111/IRV.12173

1 reference

21 June 2017

0 references

1 reference